ZA943514B - The use of dihydrolipoic acid as an ophthalmological agent and to suppress intolerance reactions in the area between implants and living body tissue - Google Patents

The use of dihydrolipoic acid as an ophthalmological agent and to suppress intolerance reactions in the area between implants and living body tissue

Info

Publication number
ZA943514B
ZA943514B ZA943514A ZA943514A ZA943514B ZA 943514 B ZA943514 B ZA 943514B ZA 943514 A ZA943514 A ZA 943514A ZA 943514 A ZA943514 A ZA 943514A ZA 943514 B ZA943514 B ZA 943514B
Authority
ZA
South Africa
Prior art keywords
implants
suppress
area
living body
body tissue
Prior art date
Application number
ZA943514A
Other languages
English (en)
Inventor
Heinz Ulrich
Erich Franz Elstner
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19934317173 external-priority patent/DE4317173C2/de
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of ZA943514B publication Critical patent/ZA943514B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA943514A 1993-05-22 1994-05-20 The use of dihydrolipoic acid as an ophthalmological agent and to suppress intolerance reactions in the area between implants and living body tissue ZA943514B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19934317173 DE4317173C2 (de) 1993-05-22 1993-05-22 Verwendung von Dihydroliponsäure als Ophthalmologicum

Publications (1)

Publication Number Publication Date
ZA943514B true ZA943514B (en) 1995-02-02

Family

ID=6488744

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA943514A ZA943514B (en) 1993-05-22 1994-05-20 The use of dihydrolipoic acid as an ophthalmological agent and to suppress intolerance reactions in the area between implants and living body tissue

Country Status (11)

Country Link
US (1) US5691379A (de)
EP (1) EP0697863A1 (de)
JP (1) JPH08511246A (de)
AU (1) AU6566794A (de)
CA (1) CA2162467A1 (de)
DE (1) DE4345199C2 (de)
IL (1) IL109701A0 (de)
PH (1) PH31652A (de)
TW (1) TW265264B (de)
WO (1) WO1994027592A1 (de)
ZA (1) ZA943514B (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19726251C2 (de) * 1997-06-20 2000-03-02 Mucos Pharma Gmbh & Co Verwendung proteolytischer Enzyme zur Behandlung von Uveitis
US5965618A (en) * 1997-11-17 1999-10-12 Perricone; Nicholas V. Treatment of scar tissue using lipoic acid
US6905707B2 (en) * 1998-05-28 2005-06-14 Medical Research Institute Controlled release arginine alpha ketoglutarate
US6191162B1 (en) 1998-05-28 2001-02-20 Medical Research Institute Method of reducing serum glucose levels
US6197340B1 (en) * 1998-05-28 2001-03-06 Medical Research Institute Controlled release lipoic acid
US20040259895A1 (en) * 1998-05-28 2004-12-23 Medical Research Institute Oral formulation of lipid soluble thiamine and lipoic acid
US20050085498A1 (en) * 1998-05-28 2005-04-21 Byrd Edward A. Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate
US6162393A (en) * 1998-08-06 2000-12-19 Ndt, Inc. Contact lens and ophthalmic solutions
US6136339A (en) * 1998-08-21 2000-10-24 Gardiner; Paul T. Food supplements and methods comprising lipoic acid and creatine
US6339102B1 (en) * 1999-06-09 2002-01-15 The United States Of America As Represented By The Secretary Of The Army Method and composition for treating and preventing retinal damage
US7678836B2 (en) * 1999-11-04 2010-03-16 Fxs Ventures, Llc Method for rendering a contact lens wettable
US20050112113A1 (en) * 2000-08-16 2005-05-26 Till Jonathan S. Presbyopia treatment by lens alteration
US7935332B2 (en) 2000-08-16 2011-05-03 Encore Health, Llc Presbyopia treatment by lens alteration
US8697109B2 (en) 2000-08-16 2014-04-15 Encore Health, Llc Caged mercaptan and seleno-mercaptan compounds and methods of using them
US7914815B2 (en) * 2000-08-16 2011-03-29 Encore Health, Llc Method for delivery of pharmaceuticals for treating or preventing presbyopia
US8795706B2 (en) 2000-08-16 2014-08-05 Encore Health, Llc Methods of treating ocular diseases using derivatives of lipoic acid
US8647612B2 (en) * 2008-03-05 2014-02-11 Encore Health, Llc Dithiol compounds, derivatives, and treatment of presbyopia
US8557868B2 (en) 2000-11-04 2013-10-15 Fxs Ventures, Llc Ophthalmic and contact lens solutions using low molecular weight amines
US20060127496A1 (en) * 2000-11-08 2006-06-15 Bioconcept Laboratories L-histidine in ophthalmic solutions
US20060148665A1 (en) * 2000-11-08 2006-07-06 Bioconcept Laboratories Ophthalmic and contact lens solutions containing forms of vitamin b
US20070110782A1 (en) * 2000-11-08 2007-05-17 Fxs Ventures, Llc L-histidine in ophthalmic solutions
EP1339418B1 (de) * 2000-11-08 2009-09-23 FXS Ventures, LLC Verbesserte ophthalmische und kontaktlinsenlösungen mit einfachen sacchariden als konservierungsverbesserer
US20070098813A1 (en) * 2000-11-08 2007-05-03 Fxs Ventures, Llc Ophthalmic and contact lens solutions with a peroxide source and a preservative
EP3045168A1 (de) * 2000-11-08 2016-07-20 FXS Ventures, LLC Verbesserte ophthalmologische und kontaktlinsenlösung
US9308264B2 (en) 2000-11-08 2016-04-12 Fxs Ventures, Llc Ophthalmic contact lens solutions containing forms of vitamin B
US9492582B2 (en) * 2000-11-08 2016-11-15 Fxs Ventures, Llc Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers
DE10229995A1 (de) * 2002-07-03 2004-01-15 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an alpha-Liponsäure
WO2004091438A2 (en) * 2003-04-15 2004-10-28 Fxs Ventures, Llc Improved ophthalmic and contact lens solutions containing peptides as representative enhancers
ITLO20060004A1 (it) * 2006-08-08 2008-02-09 River Pharma Srl "lapille" e una nuova invenzione avente per oggetto una nuova combinazione chimica stabile per uso cosmetico e farmaceutico contenente come ingredienti attivi l'acido alfa-lipoico ed il dimetilsulfossido, in grado di migliorare l'assorbimento, la bio
WO2008067403A2 (en) * 2006-11-28 2008-06-05 Encore Health Llc Presbyopia treatment by lens alteration
US8102027B2 (en) * 2007-08-21 2012-01-24 Broadcom Corporation IC package sacrificial structures for crack propagation confinement
WO2009111635A2 (en) 2008-03-05 2009-09-11 Encore Health, Llc Dithiol compounds, derivatives, and uses therefor
US9044439B2 (en) * 2008-03-05 2015-06-02 Encore Health, Llc Low dose lipoic and pharmaceutical compositions and methods
WO2010147962A1 (en) * 2009-06-15 2010-12-23 Encore Health, Llc Choline esters
KR20160145558A (ko) * 2014-03-03 2016-12-20 앙코르 비전, 인코포레이티드 리포산 콜린 에스테르 조성물 및 사용 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4002706A1 (de) * 1989-02-09 1990-08-16 Asta Pharma Ag Arzneimittel enthaltend als wirkstoff dihydroliponsaeure
DK173585B1 (da) * 1989-11-09 2001-04-02 Asta Medica Ag Anvendelse af alfa-liponsyre til fremstilling af et lægemiddel til bekæmpelse af sygdomme fremkaldt af retrovirus
DE4218572A1 (de) * 1992-06-05 1993-12-09 Asta Medica Ag Synergistische Kombination von Arzneimitteln enthaltend als Wirkstoff alpha-Liponsäure, Dihydroliponsäure, deren Metaboliten sowie die oxidierten und reduzierten Enantiomere der alpha-Liponsäure wie die R-alpha-Liponsäure oder S-alpha-Liponsäure sowie Metaboliten der alpha-Liponsäure mit den Vitaminen A, B1-6, B12, C und E

Also Published As

Publication number Publication date
PH31652A (en) 1999-01-12
DE4345199C2 (de) 1995-10-12
JPH08511246A (ja) 1996-11-26
IL109701A0 (en) 1994-08-26
AU6566794A (en) 1994-12-20
US5691379A (en) 1997-11-25
CA2162467A1 (en) 1994-12-08
TW265264B (de) 1995-12-11
WO1994027592A1 (de) 1994-12-08
DE4345199A1 (de) 1994-12-01
EP0697863A1 (de) 1996-02-28

Similar Documents

Publication Publication Date Title
ZA943514B (en) The use of dihydrolipoic acid as an ophthalmological agent and to suppress intolerance reactions in the area between implants and living body tissue
AU3886199A (en) Medical device for dissolution of tissue within the human body
HUP0103236A2 (hu) Bőr- és szövetápoló és/vagy kezelő készítmény
HUP9774641A2 (en) Gel for treatment of skin diseases and for disinfection of the skin
KR100381207B1 (de)
GB8709406D0 (en) Examining body of living tissues
IL93446A0 (en) Apparatus for selective destruction of cells,including soft tissues and bones,in a living subject's body
EP0405556A3 (en) Living hard tissue replacement, its preparation, and preparation of integral body
IL159895A0 (en) Methods of generating human cardiac cells and tissues and uses thereof
TW413028U (en) Folding-up body of moist napkin and its storage products
CA2373794A1 (en) Compositions and uses of et743 for treating cancer
GB2307295B (en) Transcutaneous measurement of substance in body tissues or fluid
PL341058A1 (en) Compositions useful in reducing weight of patient's body
TW363887B (en) Surgical implement
GB9321341D0 (en) Therapeutic compositions for use in the treatment of skin lesions and method of making same
AU3200393A (en) Body tissue omega-3 fatty-acid-augmenting agent and nutrient composition containing the same
EP0711156A4 (de) Verwendung von n-methyl-asparaginsäure zur wachstumsförderung und veränderung der körperzusammensetzung
AU7043987A (en) Fungi and algae detection in animal and human tissues and body fluids
UA2163C2 (uk) Біологічноактивний засіб, що має імуномодулюючу властивість, спосіб його одержання, препарат на його основі та спосіб нормалізації фізіологічного стану організму людини та тварин при захворюваннях, що породжені переважно функціональною недостатністю органів і тканин, із використанням такого препарату
GB9908059D0 (en) Diagnosis and treatment of diseases
HUP0204180A3 (en) External composition and its use for treating of allergic skin diseases
WO2001085185A3 (en) Treatment of il-10 deficiencies
IL94396A0 (en) Methods and mechanisms of connection between tissues in the human body
HK1040630A1 (en) A composition for eliminating undigested fat and reducing cholesterol in the human body the use thereof in the preparation of the medicament.
AU7813494A (en) Agent for use in tissues and joints of living bodies and the preparation of this agent